Rossi, Ernesto
 Distribuzione geografica
Continente #
NA - Nord America 1.939
AS - Asia 1.382
EU - Europa 1.161
SA - Sud America 229
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.768
Nazione #
US - Stati Uniti d'America 1.871
SG - Singapore 611
CN - Cina 282
SE - Svezia 214
IT - Italia 197
BR - Brasile 194
PL - Polonia 177
VN - Vietnam 168
DE - Germania 156
FR - Francia 124
IN - India 86
GB - Regno Unito 62
IE - Irlanda 54
FI - Finlandia 42
BD - Bangladesh 35
HK - Hong Kong 34
ID - Indonesia 34
CA - Canada 33
JP - Giappone 32
RU - Federazione Russa 28
CI - Costa d'Avorio 25
MX - Messico 18
TR - Turchia 18
UA - Ucraina 18
AR - Argentina 14
AT - Austria 14
ES - Italia 14
NL - Olanda 14
IQ - Iraq 12
KR - Corea 11
BE - Belgio 8
CZ - Repubblica Ceca 8
CO - Colombia 7
IR - Iran 7
UZ - Uzbekistan 7
MA - Marocco 6
PK - Pakistan 6
ZA - Sudafrica 6
CH - Svizzera 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
EG - Egitto 4
HR - Croazia 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
VE - Venezuela 4
CL - Cile 3
LT - Lituania 3
PA - Panama 3
PT - Portogallo 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
UG - Uganda 3
UY - Uruguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
ML - Mali 2
NO - Norvegia 2
NP - Nepal 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AW - Aruba 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 4.768
Città #
Singapore 380
Chandler 209
Ashburn 195
Warsaw 173
San Jose 161
Fairfield 75
New York 72
Beijing 60
Ho Chi Minh City 58
Los Angeles 56
Dublin 53
Wilmington 46
Hanoi 43
Rome 42
Lauterbourg 37
Munich 37
Hefei 36
The Dalles 36
Dallas 35
Houston 33
Hong Kong 32
Jakarta 32
Frankfurt am Main 30
Hyderabad 30
Seattle 29
São Paulo 28
Tokyo 27
St Louis 26
Woodbridge 26
Abidjan 25
Cambridge 24
Helsinki 24
Marseille 24
Princeton 22
Santa Clara 22
Milan 21
Boston 20
Nanjing 20
San Mateo 20
Moscow 19
North Bergen 19
London 18
Ann Arbor 17
Council Bluffs 17
Dearborn 15
Denver 13
Orem 13
Stockholm 13
Kent 12
Brooklyn 11
Jacksonville 11
Paris 11
Phoenix 11
Redwood City 11
Seoul 11
Atlanta 10
Düsseldorf 10
Falls Church 10
Boardman 9
Bremen 9
Cattolica 9
Chennai 9
Montreal 9
Brussels 8
Chicago 8
Falkenstein 8
Lappeenranta 8
Mexico City 8
Rio de Janeiro 8
Turku 8
Amsterdam 7
Buffalo 7
Da Nang 7
Guangzhou 7
Haiphong 7
Nanchang 7
Nuremberg 7
Poplar 7
San Diego 7
Vienna 7
Washington 7
Manchester 6
San Francisco 6
Shanghai 6
Ankara 5
Bari 5
Brasília 5
Charleston 5
Charlotte 5
Hangzhou 5
Hebei 5
Izmir 5
Mumbai 5
Ottawa 5
Prague 5
Salt Lake City 5
Amman 4
Augusta 4
Belo Horizonte 4
Changsha 4
Totale 2.843
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 346
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 341
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 227
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 167
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 154
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 153
SKIN-COBRA (Consortium for Brachytherapy data Analysis) ontology: The first step towards interdisciplinary standardized data collection for personalized oncology in skin cancer 151
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 140
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 138
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 137
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 136
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 132
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 132
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 130
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 129
Skin cancer triage and management during COVID-19 pandemic. 129
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 126
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 123
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 121
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 120
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 118
Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors 109
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 108
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 108
Single Institution Experience in the Management of Locally Advanced (pT4) Differentiated Thyroid Carcinomas 107
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 107
Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin Lesions 106
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review 106
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 104
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 102
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 96
The Role of Multidisciplinary Ocular and Periocular Cancers Meetings in Uveal Melanoma Management: A 2-Year Analysis 95
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 88
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 87
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment 83
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 65
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practice 11
Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review 3
Totale 4.835
Categoria #
all - tutte 19.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022249 26 10 6 31 14 11 9 33 14 10 32 53
2022/2023637 70 84 40 98 21 70 61 51 67 28 34 13
2023/2024357 17 81 30 22 18 59 31 9 1 15 39 35
2024/2025747 16 16 54 33 55 32 20 20 93 102 162 144
2025/20262.163 257 55 135 337 351 106 438 104 128 121 110 21
Totale 4.835